The Promise Of Genome Editing With Caribou Biosciences' Rachel Haurwitz, Ph.D.
Source: Cell & Gene
On this episode of Cell & Gene: The Podcast, Rachel Haurwitz, Ph.D., CEO at Caribou Biosciences joins Host Erin Harris to discuss the evolution of genome editing, its present state, as well as its undeniable potential. Listen now to learn more about Caribou's chRDNA genome editing technology and how it differs from CRISPR-Cas9.
This website uses cookies to ensure you get the best experience on our website. Learn more